Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
13.99
Dollar change
+0.02
Percentage change
0.14
%
IndexRUT P/E- EPS (ttm)-0.74 Insider Own63.11% Shs Outstand40.10M Perf Week0.90%
Market Cap572.89M Forward P/E- EPS next Y-1.69 Insider Trans-0.30% Shs Float15.11M Perf Month33.75%
Income-29.59M PEG- EPS next Q-0.32 Inst Own39.80% Short Float7.04% Perf Quarter37.97%
Sales0.00M P/S- EPS this Y-64.66% Inst Trans- Short Ratio6.84 Perf Half Y86.28%
Book/sh6.55 P/B2.14 EPS next Y-31.81% ROA-10.53% Short Interest1.06M Perf Year172.18%
Cash/sh6.42 P/C2.18 EPS next 5Y- ROE-10.84% 52W Range4.51 - 16.94 Perf YTD27.53%
Dividend Est.- P/FCF- EPS past 5Y- ROI-11.10% 52W High-17.41% Beta2.99
Dividend TTM- Quick Ratio66.10 Sales past 5Y0.00% Gross Margin- 52W Low210.20% ATR (14)0.98
Dividend Ex-Date- Current Ratio66.10 EPS Y/Y TTM32.17% Oper. Margin0.00% RSI (14)61.07 Volatility10.60% 6.64%
Employees30 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom2.00 Target Price13.50
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q50.98% Payout- Rel Volume0.62 Prev Close13.97
Sales Surprise- EPS Surprise164.50% Sales Q/Q- EarningsMay 15 BMO Avg Volume155.36K Price13.99
SMA2010.90% SMA5024.90% SMA20056.80% Trades Volume96,451 Change0.14%
Date Action Analyst Rating Change Price Target Change
Dec-16-22Downgrade Jefferies Buy → Hold $30 → $3.60
Dec-15-22Downgrade Morgan Stanley Overweight → Equal-Weight $5
Oct-10-22Initiated Morgan Stanley Overweight $34
Oct-10-22Initiated Jefferies Buy $30
Oct-10-22Initiated Cowen Outperform
May-20-24 04:36PM
May-15-24 12:52PM
08:05AM
May-10-24 07:02PM
Apr-15-24 07:00PM
08:30AM Loading…
Mar-28-24 08:30AM
Mar-26-24 09:02PM
01:53PM
08:05AM
Feb-26-24 04:00PM
Jan-04-24 08:00AM
Dec-29-23 12:00PM
Dec-08-23 01:05PM
Nov-09-23 09:30AM
08:30AM
08:30AM Loading…
Oct-31-23 08:30AM
Aug-31-23 08:30AM
Aug-10-23 08:10AM
Jul-26-23 09:40AM
Jul-25-23 08:30AM
Jun-09-23 08:04AM
May-24-23 11:02AM
May-11-23 05:00PM
Mar-29-23 08:05AM
Dec-23-22 06:32AM
Dec-22-22 05:41AM
Dec-15-22 10:10AM
09:53AM
08:49AM
08:22AM
07:00AM Loading…
07:00AM
Nov-21-22 04:05PM
Nov-09-22 04:15PM
Nov-02-22 08:01AM
Sep-19-22 04:10PM
Sep-15-22 11:41AM
07:58AM
Third Harmonic Bio, Inc. develops pharmaceutical products for the treatment of allergic and immune diseases and disorders. It focuses on the development of the next wave of medicine for the treatment of allergic and inflammatory diseases. The company was founded on April 25, 2019 and is headquartered in San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dittman JenniferChief Development Oper OfficerMay 20 '24Sale14.001,04214,5880May 22 04:36 PM
Dittman JenniferChief Development Oper OfficerMay 16 '24Sale14.0423,578331,0660May 20 04:33 PM
Holles Natalie C.CEOMay 09 '24Option Exercise4.2020,22284,9321,239,058May 10 04:04 PM
Holles Natalie C.CEOMay 09 '24Sale12.1820,222246,3001,218,836May 10 04:04 PM
Holles Natalie C.CEOApr 11 '24Option Exercise4.2013,55856,9441,232,394Apr 15 04:14 PM
Holles Natalie C.CEOApr 11 '24Sale12.1913,558165,2141,218,836Apr 15 04:14 PM
Person JulieCHIEF ADMINISTRATIVE OFFICERApr 04 '24Option Exercise4.201,1074,6491,107Apr 08 05:21 PM
Person JulieCHIEF ADMINISTRATIVE OFFICERApr 04 '24Sale10.001,10711,0700Apr 08 05:21 PM
Person JulieChief Administrative OfficerDec 05 '23Option Exercise4.2012,86354,02512,863Dec 07 04:04 PM
Conner Edward R.Chief Medical OfficerDec 05 '23Option Exercise4.204,79020,1184,790Dec 07 04:03 PM
Person JulieChief Administrative OfficerDec 05 '23Sale10.3012,863132,4840Dec 07 04:04 PM
Conner Edward R.Chief Medical OfficerDec 05 '23Sale10.034,79048,0620Dec 07 04:03 PM